Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

NCT03128463 is registered in ClinicalTrials.gov with Xun Xu as lead sponsor.

NCT NCT03128463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03128463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
Lead sponsor
Xun Xu
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2017
Completion date
December 31, 2018
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, conbercept, pathological myopia, pharmacogenomic, polypoidal choroidal vasculopathy